3-4675201-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 1P and 3B. PP2BP4_ModerateBP6
The NM_001378452.1(ITPR1):c.2732C>T(p.Ala911Val) variant causes a missense change. The variant allele was found at a frequency of 0.000323 in 1,611,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001378452.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITPR1 | NM_001378452.1 | c.2732C>T | p.Ala911Val | missense_variant | 23/62 | ENST00000649015.2 | NP_001365381.1 | |
ITPR1 | NM_001168272.2 | c.2687C>T | p.Ala896Val | missense_variant | 22/61 | NP_001161744.1 | ||
ITPR1 | NM_001099952.4 | c.2732C>T | p.Ala911Val | missense_variant | 23/59 | NP_001093422.2 | ||
ITPR1 | NM_002222.7 | c.2687C>T | p.Ala896Val | missense_variant | 22/58 | NP_002213.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITPR1 | ENST00000649015.2 | c.2732C>T | p.Ala911Val | missense_variant | 23/62 | NM_001378452.1 | ENSP00000497605.1 | |||
ITPR1 | ENST00000354582.12 | c.2732C>T | p.Ala911Val | missense_variant | 23/62 | 5 | ENSP00000346595.8 | |||
ITPR1 | ENST00000648266.1 | c.2732C>T | p.Ala911Val | missense_variant | 23/62 | ENSP00000498014.1 | ||||
ITPR1 | ENST00000650294.1 | c.2687C>T | p.Ala896Val | missense_variant | 22/61 | ENSP00000498056.1 | ||||
ITPR1 | ENST00000443694.5 | c.2687C>T | p.Ala896Val | missense_variant | 22/61 | 1 | ENSP00000401671.2 | |||
ITPR1 | ENST00000648309.1 | c.2687C>T | p.Ala896Val | missense_variant | 20/59 | ENSP00000497026.1 | ||||
ITPR1 | ENST00000357086.10 | c.2732C>T | p.Ala911Val | missense_variant | 23/59 | 1 | ENSP00000349597.4 | |||
ITPR1 | ENST00000456211.8 | c.2687C>T | p.Ala896Val | missense_variant | 22/58 | 1 | ENSP00000397885.2 | |||
ITPR1 | ENST00000648038.1 | c.569C>T | p.Ala190Val | missense_variant | 4/42 | ENSP00000497872.1 | ||||
ITPR1 | ENST00000648431.1 | c.59C>T | p.Ala20Val | missense_variant | 1/39 | ENSP00000498149.1 |
Frequencies
GnomAD3 genomes AF: 0.000408 AC: 62AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000368 AC: 91AN: 247512Hom.: 0 AF XY: 0.000380 AC XY: 51AN XY: 134292
GnomAD4 exome AF: 0.000314 AC: 459AN: 1459730Hom.: 0 Cov.: 30 AF XY: 0.000340 AC XY: 247AN XY: 726088
GnomAD4 genome AF: 0.000408 AC: 62AN: 152070Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74264
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 896 of the ITPR1 protein (p.Ala896Val). This variant is present in population databases (rs201519806, gnomAD 0.06%). This missense change has been observed in individual(s) with hereditary spastic pariplegia (PMID: 30778698). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 345716). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ITPR1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 26, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29925855, 29232918, 30778698) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jul 03, 2024 | BP4 - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 02, 2023 | The c.2687C>T (p.A896V) alteration is located in exon 22 (coding exon 20) of the ITPR1 gene. This alteration results from a C to T substitution at nucleotide position 2687, causing the alanine (A) at amino acid position 896 to be replaced by a valine (V). This variant is unlikely to be causative of spinocerebellar ataxia; however, its contribution to the development of Gillespie syndrome is uncertain. Based on data from the Genome Aggregation Database (gnomAD) database, the ITPR1 c.2687C>T alteration was observed in 0.04% (103/278904) of total alleles studied, with a frequency of 0.07% (86/127962) in the European (non-Finnish) subpopulation. This variant was identified in two families with hereditary spastic paraplegia (Elert-Dobkowska, 2019). This amino acid position is not well conserved in available vertebrate species. The p.A896V alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Spinocerebellar ataxia type 29 Benign:1
Likely benign, criteria provided, single submitter | research | Schule lab, Hertie Institute for Clinical Brain Research | Feb 09, 2018 | - - |
Autosomal dominant cerebellar ataxia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at